EUVIMEDEUVIMED entdecken
Kohortenstudie

Recurrence and Prevention of Nonimmediate Hypersensitivity Reactions to Iodinated Contrast Media: An 11-Year Cohort Study

Jiung Jeong, Hyun Jee Kim, Young-Chan Kim, Soon Ho Yoon, Hye-Ryun Kang

The Journal of Allergy and Clinical Immunology: In Practice · 2025-11 · 13 (11) · 3031-3041.e6

DOI: 10.1016/j.jaip.2025.07.042 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025-11. Verfasst von Jiung Jeong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Department of Internal Medicine, School of Medicine, Kyungpook Nat…. Hauptthemen laut MEDLINE: Contrast Media, Drug Hypersensitivity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Ministry of Food and Drug Safety.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: With the increasing use of low-osmolar contrast media (LOCM), hypersensitivity reactions (HSRs) to LOCM have become more common. Although guidelines for the preventive measure for immediate reactions are well established, evidence-based strategies for nonimmediate HSRs remain limited. OBJECTIVE: To determine effective prophylactic strategies for patients with nonimmediate HSRs to LOCM. METHODS: A retrospective cohort study was conducted at the Seoul National University Hospital, involving 4331 patients with nonimmediate HSRs to LOCM from 2012 to 2022. RESULTS: A total of 694 patients underwent 3634 re-exposures to LOCM; the overall recurrence rate was 3.6% per exposure (13.4% per patient). Logistic regression analysis revealed that switching to an LOCM with a different side chain (adjusted odds ratio [aOR], 0.27; 95% confidence interval [CI]: 0.15-0.53; P < .001) and antihistamine premedication (aOR, 0.47; 95% CI: 0.28-0.77; P = .003) reduced the risk of recurrence. For pruritus, urticaria, or angioedema, switching to an LOCM with a different side chain (aOR, 0.32; 95% CI: 0.13-0.75; P = .009) and antihistamine premedication (aOR, 0.37; 95% CI: 0.19-0.73; P = .004) reduced the risk of recurrence. For maculopapular rash, any LOCM change was beneficial (common side chain: aOR, 0.05; 95% CI: 0.01-0.53; P = .012; different side chain: aOR, 0.15; 95% CI: 0.05-0.47; P = .001), while premedication showed no significant effect. CONCLUSIONS: Prophylactic strategies for nonimmediate HSRs to LOCM should be tailored to clinical presentation: antihistamine premedication and side chain substitution are effective for urticaria or angioedema, whereas a maculopapular rash benefits only from switching to an alternative agent without additional benefit from antihistamine premedication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaDrug HypersensitivityHumansMaleFemaleRetrospective StudiesMiddle AgedRecurrenceAgedAdultHistamine AntagonistsCohort StudiesPremedicationUrticaria

Stichwörter der Autor:innen

Contrast mediaDelayed hypersensitivityPremedicationPrevention and controlRecurrence

Substanzen

Contrast MediaHistamine Antagonists

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Drug Safety Center, Seoul National University Hospital, Seoul, Korea; Department of Pharmacy, Seoul National University Hospital, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Drug Safety Center, Seoul National University Hospital, Seoul, Korea; Institute of Allergy and Clinical Immunology, Seoul National Unive…

Förderung

  • Ministry of Food and Drug Safety

Zitieren

APA

Jeong, J., Kim, H. J., Kim, Y. C., Yoon, S. H., & Kang, H. R. (2025). Recurrence and Prevention of Nonimmediate Hypersensitivity Reactions to Iodinated Contrast Media: An 11-Year Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice, 13(11), 3031-3041.e6. https://doi.org/10.1016/j.jaip.2025.07.042

Vancouver

Jeong J, Kim HJ, Kim YC, Yoon SH, Kang HR. Recurrence and Prevention of Nonimmediate Hypersensitivity Reactions to Iodinated Contrast Media: An 11-Year Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice. 2025;13(11):3031-3041.e6. doi:10.1016/j.jaip.2025.07.042

BibTeX
@article{Jeong2025,
  author = {Jeong, Jiung and Kim, Hyun Jee and Kim, Young-Chan and Yoon, Soon Ho and Kang, Hye-Ryun},
  title = {Recurrence and Prevention of Nonimmediate Hypersensitivity Reactions to Iodinated Contrast Media: An 11-Year Cohort Study},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2025},
  volume = {13},
  number = {11},
  pages = {3031--3041.e6},
  doi = {10.1016/j.jaip.2025.07.042}
}
Kostenlos starten →